Estrus is that period of the reproductive cycle in mammalian females in which ovulation occurs and the female is typically most receptive to mating. In rodents, the most commonly used laboratory model for studies of reproduction, estrus follows the surge of estrogen produced by the maturing ovarian follicles during proestrus. Thus, chemicals that induce estrus, or a biological response associated with estrus, are traditionally defined as estrogens (1) . The capacity of a substance to induce such effects is termed estrogenicity.
With growing concern that estrogenic chemicals in the environment, either naturally occurring or man-made, may adversely affect the health of humans, domestic animals, and wildlife (2, 3) , the need for meaningful, standardized, and widely accepted methods for reliably detecting and characterizing estrogenic chemicals has gained importance. Many assays for estrogenicity have been proposed and several are in broad use. Descriptions of many of these are found in the proceedings of the conference on Estrogens in the Environment, III: Global Health Implications (4) .
Because of the multiple biological effects of estrogens and the influence of absorption, metabolism, distribution, and excretion on the manifestation of their estrogenic activity, any single assay can provide only limited information on those effects. In vitro assays can provide valuable insights on mechanisms of action but are restricted in their capacity to mimic whole animal metabolism and distribution. In vivo assays permit the detection of effects resulting from multiple mechanisms but may give indications only of gross effects and reveal little about mechanisms of activity.
In an initial effort to assess the utility of using a combination of in vitro and in vivo assays to screen for estrogenicity, 10 known or alleged estrogenic chemicals were tested using assays that assess estrogenic activity at three different levels ofaction. The first assay, competitive binding with the estrogen receptor (ER), uses a cell-free system to determine the extent to which the test chemical binds to the ER, as reflected by its effect on the binding of 170-estradiol (5 Transcriptional activation assay in ERtransfected HeLa cells. HeLa cells were used because of their estrogen responsiveness in the presence of ER and estrogens, allowing for detection of weak estrogens. In addition, they can be treated in serum-free media to ensure that the estrogen background is null. Testing with and without the ER proves that any response is through direct interactions with the ER. The mouse ER was used in these experiments for consistency among the three assays.
The estrogen responsive reporter vector, ERET81CAT, and the pRSV vector containing the mouse ER cDNA (without the neomycin resistance cassette) was constructed as previously described (9) . HeLa cells, which do not contain ER, were cotransfected with both vectors or with only the ERET8 1 CAT vector to determine if observed activity was ER dependent. The cells were grown in DMEM/F12 medium (1:1) without phenol red (Sigma), supplemented with 5% fetal bovine serum and penicillin-streptomycin. Cells were electroporated and treated as previously described (6) . During 
Results and Discussion
Results of the competitive binding (Fig. 2) , transcriptional activation (Fig. 3,4 O Kepone transfection assay (Fig. 3) and the receptor binding assay (Fig. 2) (12, 13) . In contrast to tamoxifen, methoxychlor exhibits no intrinsic estrogenic activity, and conversion to HPTE is required for activity. No activity was seen with methoxychlor in either in vitro assay, whereas HPTE was clearly active in both assays (Fig. 2,3 ). In contrast, methoxychlor induced large increases in uterine weights ...0.0 O at high doses and, although HPTE was active in the same dose range, it produced much smaller increases in uterine weights TE, 2-2-bis(p-hydroxyphenyl)-1,1,1- (Fig. 5) . These results suggest that subcutah various concentrations of chemineous exposure to HPTE results in lower e sacrificed on the morning of the target organ concentrations than does equal dy weights was plotted. Numbers exposure to the parent compound. This um of five animals.
may be due to greater reactivity of the active metabolite and more rapid inactivation or detoxification.
o,p'-DDT and nonylphenol are environmental contaminants with reported itrol estrogenic activity (14) (15) (16) (17) (18) (19) of the test systems and to proOver the same dose range where effects e data against which to comwere seen with nonylphenol, o,p'-DDT Its of the other eight chemi-gave a greater response in the receptor bind-*oduced the effects expected, ing assay (Fig. 2) . Although o,p'-DDT gave Lbstantially greater estrogenic a response in the transfection assay (Fig. 3) , three assays than any of the it was less active than nonylphenol. o,p'-iemicals.
DDT was uterotropic (Fig. 5) , showing ,t cancer adjuvant therapeutic roughly the same level of effect in the same ifen and its metabolite, 4-dose range as HPTE and nonylphenol.
Articles * Shelby et al.
In the present studies, the reported estrogenic chemicals endosulfan (20) and kepone (13, (21) (22) (23) (24) were both negative in the receptor binding assay (Fig. 2) and the transcriptional activation assay (Fig. 3) , indicating no activity in vitro. These kepone results are in contrast to reports of binding to the estrogen receptors of animals other than mice. Consistent with these negative results in vitro, endosulfan was negative in the uterotropic assay (Fig.  5) . However, kepone gave a small doserelated increase in uterine weights over a dose range of 100-10,000 pg/kg (Fig. 5) . This result agrees with earlier reports of similar effects in birds and rats (13) and mice (24) . In the uterotropic assay, test doses for both endosulfan and kepone were limited to 10,000 pg/kg by toxicity. Further studies on the estrogenic potential of these two chemicals are underway.
As seen in Table 1 , results were the same in the two in vitro assays for all 10 chemicals. Because these two assays measure different endpoints, they should not, at this time, be considered redundant. Testing This three-test combination offers a systematic and mechanistically informative approach to assessing estrogenicity. It provides a useful profile of activity using a reasonable amount of resources and is compatible with the study of individual chemicals as well as the investigation of interactions among combinations of chemicals. Such an approach is needed if the presence of estrogenic agents in the environment is to be determined as a first step toward assessing the health hazards they may present to humans and other forms of life.
